Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
The World Allergy Organization Journal
|
February 22, 2020
Adherence to omalizumab: A multicenter "real-world" study
Raffaele Campisi, Claudia Crimi, Rossella Intravaia, et al.
Biomedicines
|
December 24, 2021
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
Corrado Pelaia, Claudia Crimi, Santi Nolasco, et al.
ERJ Open Research
|
June 10, 2025
Impact of long-term high-flow nasal therapy on mucus plugs in patients with bronchiectasis
Claudia Crimi, Santi Nolasco, Raffaele Campisi, et al.
Journal of Clinical Medicine
|
December 23, 2022
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study
Claudia Crimi, Santi Nolasco, Raffaele Campisi, et al.
Journal of Asthma and Allergy
|
June 3, 2021
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program
Raffaele Campisi, Claudia Crimi, Santi Nolasco, et al.
Journal of Clinical Medicine
|
June 28, 2023
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
Raffaele Campisi, Santi Nolasco, Corrado Pelaia, et al.
Journal of Clinical Medicine
|
January 28, 2026
Short-Term Effects of Dupilumab in Eosinophilic COPD
Chiara Lupia, Daniela Pastore, Giuseppina Marrazzo, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 22, 2021
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study
Santi Nolasco, Claudia Crimi, Corrado Pelaia, et al.
ERJ Open Research
|
November 1, 2023
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
Andrea Portacci, Raffaele Campisi, Enrico Buonamico, et al.
Frontiers in Immunology
|
July 17, 2023
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
Santi Nolasco, Andrea Portacci, Raffaele Campisi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
The World Allergy Organization Journal
|
February 22, 2020
Adherence to omalizumab: A multicenter "real-world" study
Raffaele Campisi, Claudia Crimi, Rossella Intravaia, et al.
Biomedicines
|
December 24, 2021
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
Corrado Pelaia, Claudia Crimi, Santi Nolasco, et al.
ERJ Open Research
|
June 10, 2025
Impact of long-term high-flow nasal therapy on mucus plugs in patients with bronchiectasis
Claudia Crimi, Santi Nolasco, Raffaele Campisi, et al.
Journal of Clinical Medicine
|
December 23, 2022
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study
Claudia Crimi, Santi Nolasco, Raffaele Campisi, et al.
Journal of Asthma and Allergy
|
June 3, 2021
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program
Raffaele Campisi, Claudia Crimi, Santi Nolasco, et al.
Journal of Clinical Medicine
|
June 28, 2023
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
Raffaele Campisi, Santi Nolasco, Corrado Pelaia, et al.
Journal of Clinical Medicine
|
January 28, 2026
Short-Term Effects of Dupilumab in Eosinophilic COPD
Chiara Lupia, Daniela Pastore, Giuseppina Marrazzo, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 22, 2021
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study
Santi Nolasco, Claudia Crimi, Corrado Pelaia, et al.
ERJ Open Research
|
November 1, 2023
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
Andrea Portacci, Raffaele Campisi, Enrico Buonamico, et al.
Frontiers in Immunology
|
July 17, 2023
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
Santi Nolasco, Andrea Portacci, Raffaele Campisi, et al.
Page
of 5